SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Acuite assigns ratings to Zim Laboratories’ bank facilities

08 Mar 2019 Evaluate

Credit rating agency Acuite has assigned ratings to Zim Laboratories’ Rs 125.50 crore bank facilities. The agency has assigned long-term rating of ‘BBB-’ and a Short Term rating of ‘A3’. Outlook for the long-term rating remained negative.
 
Zim Laboratories has established itself as one of the preferred healthcare solution providers in the field of New Drug Delivery Systems (NDDS).

Zim Laboratories Share Price

79.72 3.72 (4.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×